Image

eHealth Intervention to Manage Depression and Anxiety in Patients With Ischemic Heart Disease

Recruiting
18 years of age
Both
Phase N/A

Overview

This study evaluates the effectiveness and cost-effectiveness of a therapy-assisted internet-based intervention in patients with ischemic heart disease and co-morbid depression and anxiety referred for cardiac rehabilitation. Half of the patients will receive the intervention and the other half usual care. We hypothesize that the intervention will lead to a reduction in patients' symptoms of depression and anxiety and be cost-effective.

Description

The 12-week intervention will consist of 9 modules and 2 optional modules that will be delivered to patients in the active intervention via a platform or app. Psychologists will provide asynchronous guidance via the platform. Motivational interviewing will be used during the intervention to prevent dropout. The psychologist may contact patients via telephone during the intervention if needed. All patients will have access to the intervention up to 6 months' post intervention so that they can revisit the material and reuse it on a need-to-basis. Patients will be recommended to use this option and to note specific time points in their agenda where they will access the intervention. A brief purpose-designed interview protocol that includes elements from the SCAN interview will be carried out by psychologists trained in conducting the interview.

Eligibility

Inclusion Criteria:

  • Age ≥ 18 years
  • Diagnosis of ischemic heart disease (diagnostic codes I20-I25)
  • Referred for CR
  • HADS score ≥ 8 on depression and or anxiety
  • Access to a computer or smart phone
  • Ability to use computer or smart phone
  • Proficient in the Danish language
  • Signing an informed consent form

Exclusion Criteria:

  • Severe psychiatric disorder (i.e., borderline disorder, schizophrenia or bipolar disorder)
  • Severe cognitive difficulties (e.g. severe brain damage, mental retardation, or dementia) that will prevent patients from participating
  • Endorsement of suicidal ideation with daily suicidal thoughts (PHQ-9 item 9 >2)
  • Participation in other intervention studies (unless they are clinical studies)
  • Seeing a psychologist or mental health professional for the treatment of anxiety and depression

Study details

Depression, Anxiety

NCT04172974

University of Southern Denmark

26 January 2024

Rewrite in simple language using AI

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.